Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The firm's antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada in March 2010 and is headquartered in Redwood City, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
71
Frequently Asked Questions
What is Market Cap of Rezolute Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Rezolute Inc market cap is $834.71M.
What is the 52-week high for Rezolute Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rezolute Inc 52 week high is $10.04 as of October 25, 2025.
What is the 52-week low for Rezolute Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rezolute Inc 52 week low is $2.22 as of October 25, 2025.
What is the PE ratio of Rezolute Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Rezolute Inc’s P/E ratio is -9.44.
What is the Price-to-Book ratio of Rezolute Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Rezolute Inc P/B ratio is 4.9313.
What is the 50-day moving average of Rezolute Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Rezolute Inc 50-day moving average is $8.13.
